Interestingly, haptoglobin effectively differentiated low-grade bladder cancer patients from controls with high accuracy (AUC > 0.87), suggesting its potential as a biomarker for early bladder cancer detection, pending further validation [24]. The gene discussed is HP; the disease is urinary bladder cancer.